Replies to post #294782 on Innovation Pharmaceuticals Inc (IPIX)

[farrell90]

That is a good point:

Remdesivir is first gen treatment

Brilacidin could be the second gen treatment

GLTA Farrell

[Roger 2]

.Remdesivir was a boarder-line efficacious at best...

Per CDC average CV related hospital stay for survivors of the disease is 10 to 13 days.

Initial reporting put hospital release for Remdesivir treated patients at two weeks. GILD endpoints were set at 29 days of treatment. Seems that setting the endpoints at twice the average hospital stay would ensure very good trial outcomes.

I'd be more than a little embarrassed at having to portray findings in a positive light.